# Revolution Medicines, Inc. (RVMD) FY2025 Annual P&L / Income Statement

- Company: Revolution Medicines, Inc. (RVMD)
- Period: 2025-01-01 to 2025-12-31
- Filing: FY2025 10-K, filed 2026-02-25, accession number 0001193125-26-071563
- Page: https://plicit.ai/financials/rvmd/fy2025-annual-income-statement
- Chart image: https://plicit.ai/charts/rvmd-fy2025-annual-income-statement-sankey.png

## Chart details

Income statement for 2025-01-01 through 2025-12-31. Consolidated revenue, costs and expenses.

- **Total revenue**: 0 US dollars
- **Total operating expenses**: 1,182,369,000 US dollars
- **Loss from operations**: negative 1,182,369,000 US dollars
- **Total non-operating income, net**: 51,068,000 US dollars
- **Income (loss) before provision for income taxes**: negative 1,131,301,000 US dollars
- **Benefit from income taxes**: 0 US dollars
- **Net loss**: negative 1,131,301,000 US dollars
- **Total operating expenses**: 1,182,369,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.